# Expanded Access Program for OOS Obe-cel

> **NCT06799221** · — · AVAILABLE · sponsor: **Autolus Limited**

## Conditions studied

- Lymphoblastic Leukemia, Acute, Adult
- B Cell ALL

## Interventions

- **BIOLOGICAL:** Out-of-specification obecabtagene autoleucel

## Key facts

- **NCT ID:** NCT06799221
- **Lead sponsor:** Autolus Limited
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** AVAILABLE
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2026-02-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06799221

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06799221, "Expanded Access Program for OOS Obe-cel". Retrieved via AI Analytics 2026-07-24 from https://api.ai-analytics.org/clinical/NCT06799221. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*